20 Nordic companies to compete for Life Science awards at NLSDays 2024

The competition will showcase cutting-edge innovations to investors, industry leaders, and delegates.

SwedenBIO is thrilled to announce that twenty promising life science companies from the Nordic region have been shortlisted to compete in the prestigious Nordic Stars pitch competition at Nordic Life Science Days (NLSDays) 2024. This event will take place in Malmö on September 18-19 and will showcase cutting-edge innovations to an audience of investors, industry leaders, and conference delegates.

Meet the Future of Nordic Life Science

These small- and medium-sized private companies, hailing from various Nordic countries, are deeply engaged in health, medicine, and life science research and development. Each company will have the opportunity to deliver a four-minute pitch, aiming to attract new investors and business partners through both their presentation and the conference’s partnering system.

In addition to potential investor interest, the competitors will vie for a significant prize awarded during the NLSDays closing ceremony. The company deemed to have the highest investment potential by a jury of investors and pharma representatives will receive a prize of €10,000 in cash, in-kind services, and two full-access tickets to NLSDays 2025.

The Expert Jury

All applicants were rigorously assessed by an expert panel, which selected the 20 companies to participate at NLSDays. This jury will also judge the pitches at the event. The panel includes:

  • Elena Fernandez Kleinlein – JLABS EMEA Johnson & Johnson
  • Dr. Sara Kangaspeska – Innovestor
  • Dr. Markus Dietrich – Hadean Ventures
  • Inka Mero – Voima Ventures
  • Dr. Chloé Leprêtre – Servier
  • Dr. Lovisa Backemar – EIR Ventures
  • Dr. Marjo Puumalainen – SwedenBIO

“There was great diversity among the applicants, making the selection challenging. Many of the selected companies show high investment potential, and I am eager to meet them at NLSDays to learn more about their technologies,” said Dr. Sara Kangaspeska from Innovestor.

The Selected Companies

The 20 small- and medium-sized companies selected to present at NLSDays are:

  • Probmet
  • Loma Therapeutics
  • Droplet IV
  • DECORADE Therapeutics
  • metaLead Therapeutics ApS
  • Pephexia Therapeutics ApS
  • im.Engine
  • Dora Health Ab
  • Smart PD Solutions Ltd. / Kiwecare
  • Bulbitech AS
  • DoMore Diagnostics
  • Alder Therapeutics
  • Paindrainer AB
  • Rarity Bioscience
  • BrainLink
  • AKIRA Science AB
  • BrainZell AB
  • Countagen AB
  • MyCural Therapeutics
  • Intelligent Implants

NLSDays 2024 promises to be an exciting event, highlighting the cutting-edge innovations from the Nordic life science sector and providing a valuable platform for these companies to connect with potential investors and partners.